BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22466647)

  • 1. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
    Wang CA; Jedlicka P; Patrick AN; Micalizzi DS; Lemmer KC; Deitsch E; Casás-Selves M; Harrell JC; Ford HL
    J Clin Invest; 2012 May; 122(5):1895-906. PubMed ID: 22466647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.
    Liu D; Li L; Zhang XX; Wan DY; Xi BX; Hu Z; Ding WC; Zhu D; Wang XL; Wang W; Feng ZH; Wang H; Ma D; Gao QL
    Cancer Res; 2014 Oct; 74(19):5597-607. PubMed ID: 25142796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Six1,TGF-β,VEGF-C that promoting tumor lymphangiogenesis in human laryngeal carcinoma xenografts in nude mice].
    Wang L; Zhu MS; Tian JH; Xue HT; Liu HL; Zhang JH
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 30(24):1960-1964. PubMed ID: 29798275
    [No Abstract]   [Full Text] [Related]  

  • 4. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer.
    Shibata MA; Shibata E; Morimoto J; Harada-Shiba M
    Anticancer Res; 2013 Oct; 33(10):4237-47. PubMed ID: 24122987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
    Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
    Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant.
    Shibata MA; Ambati J; Shibata E; Yoshidome K; Harada-Shiba M
    Med Mol Morphol; 2012 Dec; 45(4):179-84. PubMed ID: 23224595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
    Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
    J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
    Shibata MA; Morimoto J; Shibata E; Otsuki Y
    Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.
    Ding M; Fu X; Tan H; Wang R; Chen Z; Ding S
    Mol Med Rep; 2012 Nov; 6(5):1023-9. PubMed ID: 22923155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
    Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
    Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.
    Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H
    Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model.
    Quagliata L; Klusmeier S; Cremers N; Pytowski B; Harvey A; Pettis RJ; Thiele W; Sleeman JP
    Clin Exp Metastasis; 2014 Mar; 31(3):351-65. PubMed ID: 24379135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.